CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 5107 | EN 13641:2002 | Elimination or reduction of risk of infection related to in vitro diagnostic reagents | Izstrādē |
| 83299 | - | In vitro diagnostic examinations — Specifications for pre-examination processes for human specimens for the detection of infectious pathogens — Viruses, bacteria, fungi and parasites | Izstrādē |
| 26165 | prCEN ISO/TS 25680 | Medical laboratories - Calculation and expression of measurement uncertainty | Izstrādē |
| 78630 | FprEN ISO 22367 | Medical laboratories - Application of risk management to medical laboratories (ISO/FDIS 22637:2026) | Izstrādē |
| 78864 | EN ISO 23640:2015/prA11 | In vitro diagnostic medical devices - Evaluation of stability of in vitro diagnostic reagents | Izstrādē |
| 29677 | prEN 1659 | In vitro diagnostic systems - Culture media for microbiology - Terms and definitions | Izstrādē |
| 83075 | EN ISO 15195:2019/prA1 | Laboratory medicine — Requirements for the competence of calibration laboratories using reference measurement procedures — Amendment 1 | Izstrādē |
| 83076 | prEN ISO 20776-1 rev | Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases | Izstrādē |
| 67445 | CEN/TS 17688-2:2021 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 2: Isolated proteins | Izstrādē |
| 67448 | CEN/TS 17688-3:2021 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for Fine Needle Aspirates (FNAs) - Part 3: Isolated genomic DNA | Izstrādē |
Displaying 241-250 of 276 results.